Page last updated: 2024-08-23

dazmegrel and cyclosporine

dazmegrel has been researched along with cyclosporine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barros, EJ; Boim, MA; Braquet, P; dos Santos, OF; Pirotzky, E; Schor, N1
Gladue, RP; Newborg, MF1

Other Studies

2 other study(ies) available for dazmegrel and cyclosporine

ArticleYear
Nephrotoxicity of cyclosporine: the role of platelet-activating factor and thromboxane.
    Lipids, 1991, Volume: 26, Issue:12

    Topics: Animals; Blood Pressure; Cyclosporine; Glomerular Filtration Rate; Imidazoles; Kidney; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains; Reference Values; Renal Circulation; Thromboxane A2; Thromboxane-A Synthase

1991
The protective effects of the thromboxane synthetase inhibitor Dazmegrel on nephrotoxicity in cyclosporine-treated rats.
    Transplantation, 1991, Volume: 52, Issue:5

    Topics: Acetylglucosaminidase; Amino Acid Sequence; Animals; Chromatography, Gel; Chromatography, High Pressure Liquid; Creatinine; Cyclosporine; Drug Antagonism; Encephalomyelitis, Autoimmune, Experimental; Imidazoles; Kidney; Kidney Tubules, Proximal; Male; Molecular Sequence Data; Nephrotic Syndrome; Rats; Rats, Inbred F344; Thromboxane B2; Thromboxane-A Synthase; Vasodilator Agents

1991